Filing Details

Accession Number:
0001438133-22-000065
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-10 17:01:03
Reporting Period:
2022-05-05
Accepted Time:
2022-05-10 17:01:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438133 Tandem Diabetes Care Inc TNDM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238935 J Christopher Twomey C/O Tandem Diabetes Care, Inc.
11075 Roselle Street
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-05 238 $73.73 5,270 No 4 M Indirect See Footnote
Common Stock Acquisiton 2022-05-05 135 $73.73 7,658 No 4 M Indirect See Footnotes
Common Stock Disposition 2022-05-05 158 $111.73 5,112 No 4 S Indirect See Footnote
Common Stock Disposition 2022-05-05 90 $111.73 7,568 No 4 S Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect See Footnote
No 4 M Indirect See Footnotes
No 4 S Indirect See Footnote
No 4 S Indirect See Footnotes
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant Acquisiton 2022-05-05 135 $73.73 135 $73.73
Common Stock Warrant Acquisiton 2022-05-05 238 $73.73 238 $73.73
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-05-19 No 4 M Indirect
0 2021-05-19 No 4 M Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,892 Direct
Footnotes
  1. The transaction reflects the cashless exercise of warrants to purchase common stock, at an exercise price of $73.726. Pursuant to the terms of the warrant, the shares of common stock were sold at a price equal to the average of the closing prices of the shares over the 30-day period ending three days prior to the date on which the notice of exercise was received by the Issuer.
  2. The securities are held by the Chris J. Twomey and Rebecca J. Twomey Family Trust UTD September 20, 2002.
  3. The securities are directly owned by Twomey Family Investments, LLC. The Reporting Person is co-manager of Twomey Family Investments, LLC and shares voting and investment power over the securities held by Twomey Family Investments, LLC and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Twomey Family Investments, LLC, except to the extent of his proportionate pecuniary interest therein.
  4. The expiration date for this warrant is August 31, 2022.